Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gucci Q2

This article was originally published in The Rose Sheet

Executive Summary

Yves Saint Laurent fragrance and cosmetics sales increased 5.7% on constant currency basis for fiscal second quarter ended July 31, Gucci announces in 1sales and earnings report Sept. 26. Sales were fueled by strong growth of Opium, which saw a 23.6% increase in sales during the period, company adds. Despite strength of Yves Saint Laurent, YSL Beauté consolidated sales fell 3.8% during the quarter to $104.4 mil. (€1=$.98). Beauty division still on track to achieve high single-digit revenue growth and operating margin before goodwill and trademark amortization of approximately 7%, Gucci maintains...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010649

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel